Fred Alger Management »

Edgewise Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $564k 21k 26.69

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Inc Class A Common (META)
Broadcom Common (AVGO)
Natera Common (NTRA)
Applovin Corp Class A Common (APP)
Gfl Environmental Common (GFL)
Alphabet Inc Cl C Common (GOOG)
Taiwan Semiconductor Common (TSM)
Vertiv Holdings Common (VRT)
Visa Inc Class A Shares Common (V)
Netflix Common (NFLX)
S&p Global Common (SPGI)

View all positions for Fred Alger Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Novo A/S
Vanguard Group
Cormorant Asset Management
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Henderson Group
Perceptive Advisors
TCG Crossover Management
Braidwell
Driehaus Capital Management

View all funds holding Edgewise Therapeutics